Objectives. To investigate the changes in corneal shape and optical performance during and after discontinuation of overnight orthokeratology for correction of myopia. Methods. Both eyes of 15 subjects were fitted with overnight reverse-geometry orthokeratology lenses, which were then worn for >4 hr overnight for 52 weeks. Subjects were free of ocular disease and had a corrected visual acuity of ≥1.0. Refractive correction, uncorrected visual acuity, corneal topography, and contrast sensitivity (at 4 spatial frequencies) were measured under photopic conditions. Results. Refractive error (spherical equivalent) and contrast sensitivity were decreased, whereas uncorrected visual acuity, the surface asymmetry index, and the surface regularity index were increased, 1 week after the onset of overnight orthokeratology and remained so during the 52 weeks of treatment. These parameters had largely returned to baseline values by 8 weeks after treatment discontinuation. Conclusions. Overnight orthokeratology improved uncorrected visual acuity and reduced refractive error but increased corneal irregularity and impaired contrast sensitivity. However, these changes in visual function and corneal shape were reversed after discontinuation of orthokeratology lens wear.
Omega (ω)–3 long-chain polyunsaturated fatty acids (LCPUFAs) inhibit the production of inflammatory mediators and thereby contribute to the regulation of inflammation. Experimental autoimmune uveitis (EAU) is a well-established animal model of autoimmune retinal inflammation. To investigate the potential effects of dietary intake of ω-3 LCPUFAs on uveitis, we examined the anti-inflammatory properties of these molecules in comparison with ω-6 LCPUFAs in a mouse EAU model. C57BL/6 mice were fed a diet containing ω-3 LCPUFAs or ω-6 LCPUFAs for 2 weeks before as well as after the induction of EAU by subcutaneous injection of a fragment of human interphotoreceptor retinoid-binding protein emulsified with complete Freund’s adjuvant. Both clinical and histological scores for uveitis were smaller for mice fed ω-3 LCPUFAs than for those fed ω-6 LCPUFAs. The concentrations of the T helper 1 (Th1) cytokine interferon-γ and the Th17 cytokine interleukin-17 in intraocular fluid as well as the production of these cytokines by lymph node cells were reduced for mice fed ω-3 LCPUFAs. Furthermore, the amounts of mRNAs for the Th1- and Th17-related transcription factors T-bet and RORγt, respectively, were reduced both in the retina and in lymph node cells of mice fed ω-3 LCPUFAs. Our results thus show that a diet enriched in ω-3 LCPUFAs suppressed uveitis in mice in association with inhibition of Th1 and Th17 cell function.
1 March 2011 in Eye & Contact Lens: Science & Clinical Practice
Polyhexamethylene biguanide (PHMB) exhibits broad-spectrum antimicrobial activity and is included in multipurpose solutions for contact lenses as a disinfectant. Both cationic and hydrophobic features of PHMB are believed to support its association with microbial cell membranes through electrostatic and hydrophobic interactions. We now evaluated the effects of ionic and surfactant agents on the antimicrobial activity of PHMB. The antimicrobial activity of PHMB (1 ppm) against various bacteria and fungi was measured with the stand-alone procedure (ISO 14729, 2001). The effect of NaCl as an ionic isotonic agent on such an activity was determined in comparison with that of propylene glycol as a nonionic isotonic agent. The effect of the nonionic surfactant Poloxamer 407 (Px407) was similarly examined in the absence or presence of NaCl. The antimicrobial activity of PHMB increased with time, being especially pronounced after 60 min. This activity was inhibited by NaCl in a concentration-dependent manner but was not affected by propylene glycol. Poloxamer 407 (4%) alone slightly increased the activity of PHMB toward Staphylococcus aureus and fungi. Although Px407 prevented the inhibitory effect of NaCl on PHMB activity against bacteria, it enhanced that observed with Candida albicans. The antimicrobial activity of PHMB was inhibited by adjustment of osmolality with the ionic agent NaCl but not by that with the nonionic agent propylene glycol. The surfactant Px407 exhibited complex effects on PHMB activity in the presence of NaCl. These findings indicate that the electrostatic interaction with the cell membrane is a dominant factor in the antimicrobial activity of PHMB.
Dietary ω-3 long-chain polyunsaturated fatty acids (LCPUFAs) and lutein each protect against age-related macular degeneration (AMD). We here examined the effects of ω-3 LCPUFAs and lutein supplementation in a mouse model of AMD. Mice were assigned to four groups: (1) a control group fed an ω-3 LCPUFA–free diet, (2) a lutein group fed an ω-3 LCPUFA–free diet with oral administration of lutein, (3) an ω-3 group fed an ω-3 LCPUFA–supplemented diet, and (4) an ω-3 + lutein group fed an ω-3 LCPUFA–supplemented diet with oral administration of lutein. Mice were fed the defined diets beginning 2 weeks before, and received lutein with an oral gavage needle beginning 1 week before, induction of choroidal neovascularization (CNV) by laser photocoagulation. The area of CNV measured in choroidal flat-mount preparations was significantly reduced in mice fed ω-3 LCPUFAs or lutein compared with those in the control group, and it was reduced in an additive manner in those receiving both ω-3 LCPUFAs and lutein. The concentrations of various inflammatory mediators in the retina or choroid were reduced in mice fed ω-3 LCPUFAs or lutein, but no additive effect was apparent. The generation of reactive oxygen species (ROS) in chorioretinal lesions revealed by dihydroethidium staining as well as the expression of NADPH oxidase 4 (Nox4) in the retina revealed by immunohistofluorescence and immunoblot analyses were attenuated by ω-3 LCPUFAs and lutein in a synergistic manner. Our results thus show that dietary intake of ω-3 LCPUFAs and lutein attenuated CNV in an additive manner and in association with suppression of inflammatory mediator production, ROS generation, and Nox4 expression. Dietary supplementation with both ω-3 LCPUFAs and lutein warrants further study as a means to protect against AMD.